RSS News

Pharmaceutical Industry

Drugs Licensed

Mosaic adds to cancer combo pattern by licensing 2 clinical-stage drugs from Astex - Fierce Biotech

Drug that cuts risk of breast cancer returning is approved for use in England - The Guardian

Proposed legislation paves the way for AI to prescribe drugs - MobiHealthNews

10 Drugs Approved for Primary Care: Q1 2025 - Patient Care Online

Synthetic Approaches to the New Drugs Approved during 2023 - ACS Publications

Drugs, fake license plates found in shoplifter’s stolen SUV: PD - KRON4

Thinking of buying obesity drugs online? Read this first - NPR

Pre-Exposure Prophylaxis - HIV.gov

Oncology Drugs Approved by the FDA in January 2025 - Oncology Nursing News

Drugs Patents

Halozyme sues Merck over subcutaneous Keytruda as licensing talks fall through - Fierce Pharma

Halozyme Challenges Merck in Patent Battle Over Breakthrough Subcutaneous Keytruda Technology - Stock Titan

Halozyme Sues Merck for Patent Infringement over Subcutaneous Keytruda Formulation - Yahoo Finance

Merck Faces Lawsuit to Block Launch of Easier-to-Use Keytruda - Bloomberg.com

Opinion: How patents can serve the common good - C&EN

Sponsored Content: The Connection Between Patents and High Drug Prices - Politico

What really happens to drug prices when patents expire - statnews.com

Senate Judiciary Committee to Consider Bills Targeting Pharma Patents and Pricing - IPWatchdog.com

Drug Patent Reform’s Been Postponed Repeatedly, Is The 119th Congress Ready To Act? - Forbes

Drugs Generics

Tariff hits to generic drugs could 'blow back on everybody' without supply chain resilience, says USP chief - Fierce Pharma

US tariffs on pharmaceuticals risk shortages of lower-cost generic drugs - Financial Times

American cancer drugs in Russia to be replaced by generics - realnoevremya.com

API Dependence & India’s Path To Self-Reliance In Complex Drug Manufacturing - BW Healthcare World

Pharma tariffs could be a generics problem - Axios

All generic drugs are not equal, study finds - Ohio State News

US FDA Shows Support For Generic Drug User Fee Goals Amid Cutbacks - insights.citeline.com

Trump Tariffs Could Raise Generic Drug Prices, Worsen Shortages - Pharmacy Practice News

Generic Drugs Market Size Worth $728.64 Bn by 2034 | Driven - GlobeNewswire

FDA Food and Drug Administration

US FDA suspends milk quality tests amid workforce cuts - Reuters

FDA’s milk testing program pause is not cause for alarm, experts say - The Washington Post

FDA milk quality testing program suspended after job cuts - NewsNation

Key FDA drug data goes missing amid DOGE cuts - Axios

FDA to phase out dyes used in Flamin' Hot Cheetos, Skittles and other snacks - CNBC

FDA Warns of Side Effects of Popular Hair-Loss Drug Sold by Telehealth Companies - WSJ

FDA warns unapproved hair-loss product finasteride tied to side effects - upi.com

FDA Issues Alert on Compounded Topical Finasteride Risks - Medscape

FDA head falsely claims no scientists laid off, as agency shutters food safety labs - CBS News

Pharmaceutical Companies

Drugmakers brace for Trump tariffs, while weighing numerous other worries - Reuters

Once all-powerful, pharma’s allies in Washington are fleeting - Politico

US drug firm Merck says existing Trump tariffs will cost it $200m this year - The Guardian

How Takeda's CEO transformed the company into a global pharma powerhouse - CNBC

Trump’s tariffs threaten Ireland’s pharma fortune - Financial Times

Swiss pharmaceuticals company Roche announces $50B investment in US over next 5 years - AP News

Sanofi, Novartis CEOs lambast EU price control as Trump reportedly weighs drug cost parity with other nations - Fierce Pharma

Drug Companies Step Up 'Make in America' Plans to Counter Tariffs - WSJ

An 'insane' calculus: A pharma company raised price for a rare disease drug 150% to cover Medicaid rebates - statnews.com

Retail Pharmacies

Rite Aid is considering another bankruptcy - Healthcare Brew

A New Prescription for US Pharmacy - Bain & Company

What’s open and closed on Easter Sunday? Grocery stores, Walmart, Target, pharmacies, more - Fast Company

Arkansas passes law banning PBMs from owning pharmacies - Healthcare Dive

Nearly 1 in 3 retail pharmacies have closed since 2010 - UC Berkeley School of Public Health

Arkansas governor signs bill barring PBMs from owning pharmacies - Fierce Healthcare

Committee advances PBM bill keeping CVS, others from having retail pharmacies - Talk Business & Politics

Floundering drugstore chain nears Chapter 11 bankruptcy again - TheStreet

Proposed ban on drug middlemen owning retail pharmacies passes Arkansas House committee - Arkansas Advocate

Drug Marketing

The impact of accelerated drug marketing registration procedures on the review and approval of new drugs in China - Nature

Pharmaceutical Market Size is projected to reach US$ 2.84 billion by 2031 at 7.1% CAGR - The Insight Partners - GlobeNewswire

Top leaders at FDA marketing overseer resign, potentially teeing up RFK Jr.’s promised drug ad ban: report - Fierce Pharma

China Issues New Domestic Responsible Person Rules for Foreign Drug Marketing Authorization Holders - Morgan Lewis

Johnson & Johnson unit ordered to pay $1.64 billion in HIV drug marketing case - Reuters

Opinion | Why Hasn't RFK Jr. Paused Drug Ads? - MedPage Today

How the IRA is impacting the generic drug market - PhRMA

Regulation of Drug Marketing: An Introduction - Food and Drug Law Institute (FDLI)

FDA Authorizes Marketing of 20 ZYN Nicotine Pouch Products after Extensive Scientific Review - fda.gov